Emma Ruane
In November 2021, Emma was appointed partner at Peters & Peters, marking a significant milestone in a career spanning over a decade in civil and commercial litigation. Throughout her tenure at Peters & Peters, Emma has garnered significant expertise in navigating complex legal matters, often with an international dimension.
A standout achievement in Emma's career so far is her role in representing the Republic of Mozambique in the widely recognised "tuna bonds litigation," a piece of litigation which the Lawyer magazine described as having “one of the weightiest line-ups” in 2023’s top 20 cases of the year, with around 30 parties and no fewer than 14 KCs.
Emma has a proven track record in securing interim relief, including freezing orders, anti-suit injunctions, and disclosure orders, as well as challenging the same. Her experience extends to representing both claimants and defendants through to the conclusion of trial and beyond.
Emma defended the CEO of what was one of Nigeria’s top three banks against charges of share manipulation and misappropriation in a trial, two weeks of which took place in Lagos, Nigeria. She was also a key part of the team which helped the National Health Service to prevail against allegations it failed to mitigate its losses in a multi-million pound, long-running competition claim.
Other leading and recent experiences include Emma’s co-ordination of a team for the purpose of pursuing a group claim alleging misrepresentation in tax-efficient investments, her advisory role on jurisdictional issues stemming from the sale of Indian money transfer businesses and the management of multi-party litigation relating to the sale of Formula One in 2005.
Case examples
Acting for the Republic of Mozambique in the US$2 billion “Tuna Bonds” Commercial Court proceedings against Credit Suisse and Abu Dhabi-based shipbuilder Privinvest.
Acting for a major healthcare provider on a £250 million claim against a pharmaceutical company for breaches of EU and UK competition rules.
Acting for 140 claimants in a complex multi-party tax and fraud litigation.
Acting for the Secretary of State for Health and Social Care against companies in the Reckitt Benckiser group, found by the Office of Fair Trading (now the Competition and Markets Authority) to have impeded market entry of a generic version of their blockbuster drug Gaviscon.
Represented German media group Constantin Medien in a much-publicised claim against Formula One magnate Bernie Ecclestone and in a dispute with German bank Bayerische Landesbank.